A team led by chemist Frank Glorius, a professor at the Institute of Organic Chemistry at the University of Münster, has ...

CMS rewrites star ratings calculations, prompting Medicare Advantage plans to resubmit bids and affecting 2027 quality bonus payments.

BPC-157.io, an independent peptide education and brand-comparison resource, today announced the launch of a free online calculator designed to help users estimate dose conversions between injectable ...

Going forward, insurance companies will be required to apply more conservative loss ratios when calculating insurance ...

Ultrasound can open and rebuild molecular nanocages, enabling controlled release of cancer drugs and advancing targeted drug ...

In the race to build the quantum economy, Canada has secured a valuable head start. Whether it can maintain that advantage ...

A 68-year-old opens her Annual Notice of Change in late September and sees the monthly premium on her standalone Part D drug plan jumping from $42 to $58 for the coming year. She remembers reading ...

Anthropic has entered the healthcare AI space with a drug discovery programme. The move adds it to a widening race to apply ...

By Puyaan Singh July 6 (Reuters) - Vertex Pharmaceuticals will buy Crinetics Pharmaceuticals for a total equity value of ...

An Ontario court found the employer's zero-tolerance drug policy held up. In a decision released June 25, 2026, Justice R.E.

On June 16, 2026, the Centers for Medicare & Medicaid Services (CMS) published a proposed rule that would codify the Medicare Drug Price ...

The NHS begins offering teplizumab, the first drug shown to delay type 1 diabetes and postpone insulin by nearly three years.